Deal date

KANDO id: 750126

Financial Transaction:

Series C


Color Genomics Inc


Currency
United States Dollar
Value in original currency
80,000,000
Value in USD
80,000,000

Note
“This new funding will enable Color to continue developing new tests for hereditary conditions where the science is clear and the results are actionable — and new services that help our clients proactively manage their own health.”

Lead investor

Country Notes

General Catalyst Partners

Venture capital firm that makes early-stage and transformational investments.
United States

Round participants

Country Notes

Charles River Ventures

(CRV)
Independent venture capital firm
United States

Emerson Collective

United States